Skip to content

Docteur SAMRAY Eloïse

Active Private limited companyfounded 2023active for 3 yearsRue des Gros Thiers 15, 4990 LierneuxKBO/BCE: BE 0805.535.807

Lifetime

2 annual accounts with figures on one time axis
peak €106,925 (2025)
€106,925▲ 18.6%
peak €75,014 (2025)
€75,014▲ 24.0%
peak €141,531 (2025)
€141,531▲ 113%
€94,994▲ 141%
Board1 name since 2023
Documentsfilings and deeds
19-12-202543 days before the deadline
2025micro format
Gross margin from €90,175 to €106,925Registered office moved within Lierneux 05-09Equity from €66,517 to €141,531Debts from €39,458 to €94,994Cash from €95,099 to €185,515

Key points

from the 2025 annual accounts

Equity

€141,531 ▲ 113%
€66,5002024€142,0002025

Equity rose in 2025 from €66,517 to €141,531.

Debts

€94,994 ▲ 141%
Other debts
+53,184
Taxes and wages
+2,049
The rest
+304

Debts rose by €55,537 in 2025.

Investments

€37,557 7.0 × depreciation

Green is investment, beige is depreciation.

Checked score

85
Excellent
Financially stronger than 77% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 2.5%highest value 01-2025: 0.2%▼ -2.3 percentage points vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025lowest value 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.8%▲ +0.6 percentage points vs 09-2025 11-2025: 1.0%▲ +0.2 percentage points vs 10-2025 12-2025: 1.1%▲ +0.1 percentage points vs 11-2025 01-2026: 0.3%▼ -0.8 percentage points vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.4%▲ +0.1 percentage points vs 09-2026 11-2026: 0.5%▲ +0.1 percentage points vs 10-2026

Financial strength
Strong

85-3equity 59.8% of total assets
81-2short-term debt 40.2% · cash 78.4%
100=return on assets 31.7%

Score breakdown

raises risk
1 change of registered office in 24 months
Founded in 2023
lowers risk
Size: total assets €236,526
Liquidity: current ratio 2.15, cash €185,515
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 51% of them on solvency, 74% on liquidity, 90% on profitability and 93% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-06-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as Docteur SAMRAY Eloïse has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of Docteur SAMRAY Eloïse itself: 0.5% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Docteur SAMRAY Eloïse. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €12,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.15 (2.69 in 2024), above the usual 1.5. Short-term debt is 40.2% and cash 78.4% of total assets. 40.2% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €236,526
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 2.15, cash €185,515
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-12-2025, 43 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
43 days early
2024
35 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 39 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end09-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Board and ownership

SE
Director, since 06-09-2023
  • SAMRAY Eloïse Thérèse Hilda 60 sharesdeed of 08-09-2023
Board & ownership

Recent changes

Registered office moved within Lierneux New registered office: Rue des Gros Thiers 15, 4990 LIERNEUX · Previous registered office: Brux 4, 4990 LIERNEUX · Gazette deed
Incorporation Founding capital of €6,000, 60 shares · Founder: SAMRAY Eloïse Thérèse Hilda · Appointment: SAMRAY Eloïse Thérèse Hilda (director) · published on 08-09-2023 · Gazette deed
First establishment Rue des Armées Américaines 6, Manhay
All 6 events

Official details

Source: KBO
Status
Active since 06-09-2023Normal situation
Activity
“La société a pour objet l'exercice de la médecine générale par le ou les…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO yet
Establishment unit
2.352.596.0326960 Manhay, since 06-09-2023
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

≈ €270,000estimated
€236,526▲ 123%
Filing
Filed on 19-12-2025, 43 days before the end of the filing period
Financials

Insights on Docteur SAMRAY Eloïse

Docteur SAMRAY Eloïse has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €141,531 and a net result of €75,014.

The computed 12-month bankruptcy probability is 0.5% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Docteur SAMRAY Eloïse

What is the company number of Docteur SAMRAY Eloïse?
The company number of Docteur SAMRAY Eloïse is 0805.535.807. The VAT number is the same number with BE in front: BE 0805.535.807.
Where is Docteur SAMRAY Eloïse based?
The registered office is at Rue des Gros Thiers 15, 4990 Lierneux.Company details
What is the legal form of Docteur SAMRAY Eloïse?
Docteur SAMRAY Eloïse is a private limited company (BV).
When was Docteur SAMRAY Eloïse founded?
Docteur SAMRAY Eloïse was founded on 06-09-2023.
Is Docteur SAMRAY Eloïse still active?
Yes, Docteur SAMRAY Eloïse is an active enterprise in the KBO register.
What is the turnover of Docteur SAMRAY Eloïse?
The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €106,925 and 2,205 comparable companies of the same size. It probably lies between €180,000 and €410,000. It is a rough estimate.Financials
Is Docteur SAMRAY Eloïse profitable?
In financial year 2025, Docteur SAMRAY Eloïse made a profit of €75,014.
Where can I find the annual accounts of Docteur SAMRAY Eloïse?
Docteur SAMRAY Eloïse filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Docteur SAMRAY Eloïse due?
Docteur SAMRAY Eloïse must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.